Items where authors include "Silber, E."

Article

Muraro, P.A. orcid.org/0000-0002-3822-1218, Kazmi, M., De Matteis, E. et al. (16 more authors) (2025) Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK. Journal of Neurology, Neurosurgery & Psychiatry. ISSN 0022-3050

Kazmi, M. orcid.org/0000-0002-6863-6297, Muraro, P.A., Mehra, V. orcid.org/0000-0001-6572-0971 et al. (16 more authors) (2025) Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: a 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT). British Journal of Haematology. ISSN 0007-1048

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

Brittain, G. orcid.org/0000-0002-9903-7203, Petrie, J. orcid.org/0000-0001-6150-6724, Duffy, K.E.M. et al. (25 more authors) (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14 (2). e083582. ISSN 2044-6055

Bogosian, A., Day, F., Norton, S. et al. (4 more authors) (2022) Key demographics and psychological skills associated with adjustment to progressive multiple sclerosis early in the diagnosis. Frontiers in Rehabilitation Sciences, 3. ISSN 2673-6861

Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2864

Allen-Philbey, K., De Trane, S., Mao, Z. et al. (35 more authors) (2021) Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Therapeutic Advances in Neurological Disorders, 14. ISSN 1756-2856